Literature DB >> 27635300

Urothelial carcinoma of the allograft kidney developed in a renal transplant patient.

Mehmet İlker Gökçe1, Akın Fırat Kocaay2, Serkan Aktürk3, Acar Tüzüner2.   

Abstract

Renal transplantation is the best option in the treatment of end-stage renal disease However these patients are under the risk of developing malignancies particularly due to effects of immune supression. These malignancies tend to be more agressive compared to the general population. Here, we present a case of urothelial carcinoma develoing in the ureter of allograft kidney.

Entities:  

Keywords:  Nephroureterectomy; renal transplantation; urothelial carcinoma

Year:  2016        PMID： 27635300      PMCID： PMC5012452          DOI： 10.5152/tud.2016.97415

Source DB:  PubMed          Journal:  Turk J Urol        ISSN： 2149-3235


  12 in total

1.  Conservative surgical treatment of low-grade urothelial carcinoma in the renal allograft recipient: a case report.

Authors:  I Mokos; J Pasini; R Stern-Padovan; S Mrsic; S Ries
Journal:  Transplant Proc       Date:  2006-06       Impact factor: 1.066

2.  Transitional cell carcinoma in a renal allograft.

Authors:  I Vervloessem; R Oyen; Y Vanrenterghem; H Van Poppel; P Van Hover; G Debakker; A L Baert
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

3.  Bladder cancer in renal transplant recipients.

Authors:  B D Buzzeo; D M Heisey; E M Messing
Journal:  Urology       Date:  1997-10       Impact factor: 2.649

4.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Authors:  R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

5.  Urothelial cancers after renal transplantation.

Authors:  Jared Cox; Janet L Colli
Journal:  Int Urol Nephrol       Date:  2011-03-04       Impact factor: 2.370

6.  Primary kidney tumors before and after renal transplantation.

Authors:  I Penn
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

7.  Comparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation.

Authors:  Ozan Ekmekçioğlu; Sadi Turkan; Şener Yıldız; Zeki Ender Güneş
Journal:  Turk J Urol       Date:  2013-03

Review 8.  Treatment and outcome of invasive bladder cancer in patients after renal transplantation.

Authors:  Viraj A Master; Maxwell V Meng; Gary D Grossfeld; Theresa M Koppie; Ryutaro Hirose; Peter R Carroll
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

9.  Concurrent urothelial carcinoma in the renal pelvis of an allograft kidney and native recipient bladder: evidence of donor origin.

Authors:  Ei-ichiro Takaoka; Jun Miyazaki; Tomokazu Kimura; Takahiro Kojima; Koji Kawai; Yoshihiko Murata; Naoe Itoguchi; Yuko Minami; Takako Nakamura; Katsuya Honda; Hiroyuki Nishiyama
Journal:  Jpn J Clin Oncol       Date:  2014-03-03       Impact factor: 3.019

10.  Transitional cell carcinoma in renal transplant recipients: a single center experience.

Authors:  Xiao-Bei Li; Nian-Zeng Xing; Yong Wang; Xiao-Peng Hu; Hang Yin; Xiao-Dong Zhang
Journal:  Int J Urol       Date:  2008-01       Impact factor: 3.369
View more
  1 in total

1.  Urothelial carcinoma of the graft kidney with molecular analyses: a rare case report.

Authors:  Joyce M Chen; G Kenneth Haines; William Lam; Asha Reddy; Meenakshi Mehrotra; Jane Houldsworth; Qiusheng Si
Journal:  Diagn Pathol       Date:  2021-06-14       Impact factor: 2.644
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.